Abstract:Since it was first recognized in bacteria and archaea as a mechanism for innate viral immunity in the early 2010s, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) has rapidly been developed into a robust, multifunctional genome editing tool with many uses. Following the discovery of the initial CRISPR/Cas-based system, the technology has been advanced to facilitate a multitude of different functions. These include development as a base editor, prime editor, epigenetic editor, and CRISPR interference (CRISPRi) and CRISPR activator (CRISPRa) gene regulators. It can also be used for chromatin and RNA targeting and imaging. Its applications have proved revolutionary across numerous biological fields, especially in biomedical and agricultural improvement. As a diagnostic tool, CRISPR has been developed to aid the detection and screening of both human and plant diseases, and has even been applied during the current coronavirus disease 2019 (COVID-19) pandemic. CRISPR/Cas is also being trialed as a new form of gene therapy for treating various human diseases, including cancers, and has aided drug development. In terms of agricultural breeding, precise targeting of biological pathways via CRISPR/Cas has been key to regulating molecular biosynthesis and allowing modification of proteins, starch, oil, and other functional components for crop improvement. Adding to this, CRISPR/Cas has been shown capable of significantly enhancing both plant tolerance to environmental stresses and overall crop yield via the targeting of various agronomically important gene regulators. Looking to the future, increasing the efficiency and precision of CRISPR/Cas delivery systems and limiting off-target activity are two major challenges for wider application of the technology. This review provides an in-depth overview of current CRISPR development, including the advantages and disadvantages of the technology, recent applications, and future considerations.

The discovery and development of Cas12A

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Expanding the CRISPR toolbox by engineering Cas12a orthologs of metagenomic discovery

Improved genome editing by an engineered CRISPR-Cas12a

An update on CRISPR-Cas12 as a versatile tool in genome editing

Recent advances of Cas12a applications in bacteria

Discovery and engineering of ChCas12b for precise genome editing

High-Throughput Profiling of Cas12a Orthologues and Engineered Variants for Enhanced Genome Editing Activity

The CRISPR tool kit for genome editing and beyond

A New RNA-Dependent Cas12g Nuclease

Structure and genome editing activity of the novel CRISPR-Cas12o1 effector

Disruptive Technology: CRISPR/Cas-Based Tools and Approaches

CRISPR/Cas9 in Genome Editing and Beyond

The application and development of CRISPR Cas9

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing

Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates

CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Application of CRISPR/Cas9 for Biomedical Discoveries

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Recent Progress in CRISPR/Cas9 Technology